Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19.
Lowe DM, Brown LK, Chowdhury K, Davey S, Yee P, Ikeji F, Ndoutoumou A, Shah D, Lennon A, Rai A, Agyeman AA, Checkley A, Longley N, Dehbi HM, Freemantle N, Breuer J, Standing JF; FLARE Investigators. Lowe DM, et al. Among authors: longley n. PLoS Med. 2022 Oct 19;19(10):e1004120. doi: 10.1371/journal.pmed.1004120. eCollection 2022 Oct. PLoS Med. 2022. PMID: 36260627 Free PMC article. Clinical Trial.
Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19.
Levin MJ, Ustianowski A, De Wit S, Launay O, Avila M, Templeton A, Yuan Y, Seegobin S, Ellery A, Levinson DJ, Ambery P, Arends RH, Beavon R, Dey K, Garbes P, Kelly EJ, Koh GCKW, Near KA, Padilla KW, Psachoulia K, Sharbaugh A, Streicher K, Pangalos MN, Esser MT; PROVENT Study Group. Levin MJ, et al. N Engl J Med. 2022 Jun 9;386(23):2188-2200. doi: 10.1056/NEJMoa2116620. Epub 2022 Apr 20. N Engl J Med. 2022. PMID: 35443106 Free PMC article. Clinical Trial.
Streamlining malaria prevention recommendations for travellers: current and future approaches.
McGuinness SL, Veit O, Angelin M, Antonini P, Boecken G, Boering M, Bühler S, Calleri G, Éperon G, Flaherty G, Gossner C, Askling HH, Holmberg V, Kuenzli E, Landry P, Lefevre E, Libman M, Longley N, Maniewski-Kelner U, Neumayr A, Rapp C, Ridpath AD, Rodriguez-Valero N, Rosdahl A, Rosenbusch D, Rossanese A, Rothe C, Schlagenhauf P, Soentjens P, Staehelin C, Visser J, Visser L, Wagner A, Walker A, Wiedermann U, Wroczynska A, Hatz C. McGuinness SL, et al. Among authors: longley n. J Travel Med. 2024 Dec 10;31(8):taae113. doi: 10.1093/jtm/taae113. J Travel Med. 2024. PMID: 39167759 No abstract available.
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023: a pragmatic update.
Smith CH, Yiu ZZN, Bale T, Burden AD, Coates LC, Eckert E, Longley N, Mahil SK, McGuire A, Murphy R, Nelson-Piercy C, Owen CM, Parslew R, Woolf RT, Mansour Kiaee Z, Constantin AM, Ezejimofor MC, Exton LS, Mohd Mustapa MF. Smith CH, et al. Among authors: longley n. Br J Dermatol. 2024 Jan 23;190(2):270-272. doi: 10.1093/bjd/ljad347. Br J Dermatol. 2024. PMID: 37740557 No abstract available.
42 results